WORLD AIDS DAY: How stigma is impacting the 90-90-90 goals
The HIV epidemic is far from over and we will not reach key UNAIDS targets and control HIV unless we end HIV-related stigma, argues Prof Linda-Gail Bekker.
Opinion: When civil society can’t do its work, adherence to HIV treatment dips.
If South Africa is forced to go into a COVID-19 lockdown again, HIV support groups and adherence clubs should remain functional to make sure that everyone is supported, has regular access to information and treatment, and that people are motivated to adhere to treatment, argue Annah Maluleke and Solanga Milambo.
New medicines should make life easier for kids living with HIV
HIV medicines for children often taste bitter, pills are large, and for many children there is a lot of medication to take. This makes it hard to take treatment as prescribed. Tiyese Jeranji looks at the challenges with currently available HIV medicines for children, what innovations are in the pipeline, and how HIV treatment is being tailored to suit the needs of children.
Where are we in the race for a HIV vaccine?
While progress in the race for effective COVID-19 vaccines has been rapid and impressive, an effective HIV vaccine remains elusive. As part of Spotlight’s World AIDS Day 2020 coverage, Kathryn Cleary asks two of South Africa’s top vaccine researchers to update us on where we are in the race for an HIV vaccine.
Opinion: Why fixing South Africa’s patent laws is necessary in the fight against HIV
In 2018, Cabinet adopted a new intellectual property policy for South Africa, but as yet the policy has not led to any change in the country’s patent laws. Amending these laws as soon as possible is critical to both the COVID-19 and HIV response, argues Umunyana Rugege.
Reimagining healthcare in the Eastern Cape: Back to Basics is the right medicine to fix stockouts
Medicine stockouts can have dire consequences. Tendai Mafuma and Ruth Dube look at lessons learnt over the years on how to help prevent medicine stockouts and argue that although the interventions are not new, if implemented it could help solve the vicious cycle of medicine stockouts in the Eastern Cape.
In-depth: Women living with HIV, still waiting on redress after ‘forced sterilisations’
Almost nine months since the Commission on Gender Equality (CGE) released a damning report with dozens of women living with HIV’s testimonies about forced sterilisations allegedly performed on them in public health facilities, the Department of Health has now moved to implement the Commission’s recommendations. Nomfundo Xolo reports.
Editorial: Language matters when it comes to health-related stigma
When it comes to health, language matters. This is because poorly chosen words can subtly, or not so subtly, stigmatise groups of people, reinforce stereotypes, exclude, and discriminate.
U=U: We should put people living with HIV at the centre of HIV prevention efforts
The U=U campaign is based on a simple message – an undetectable viral load in people living with HIV equals an untransmissible virus. The U=U campaign, argues Mandisa Dukashe, has the power to motivate people living with HIV to adhere to ARVs, achieve viral suppression, and subsequently lead long and healthy lives while preventing HIV transmission to sexual partners and their babies.
HIV death rate in SA men much higher than in women
While men account for only a third of South Africa’s roughly 200 000 new HIV infections in the year ending mid-2019, they account for more than half of the approximately 74 000 HIV-related deaths in the same period. This is according to new estimates released on Tuesday from the Thembisa mathematical model of HIV in South Africa.
COVID-19: No deal yet to access “90% effective” vaccine tested in South Africa
The head of the South African arm of a key COVID-19 vaccine clinical trial is “full of pride” for the teams’ part in the research which has shown the vaccine candidate to be more than 90% effective according to early findings released this week. It however remains unclear whether the vaccine will be available in South Africa once registered. Adele Baleta reports.
HIV prevention injection hailed as a “major breakthrough” for women
Early results from a pivotal trial of an HIV prevention injection announced by the University of the Witwatersrand researchers have been hailed as being a “game-changer” to turn “the tide on HIV” as it effectively reduces HIV acquisition and provides women more choices in how to protect themselves. Amy Green reports.
